224 related articles for article (PubMed ID: 24989922)
1. [Transcatheter arterial chemoembolization with doxorubicin drug eluting beads for patients with unresectable hepatocellular carcinoma: initial experience].
Duan F; Yan J; Liu F; Song P; Wang Y; Yuan K; Wang M
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):314-5. PubMed ID: 24989922
[No Abstract] [Full Text] [Related]
2. [Transcatheter arterial chemoembolization with doxorubicin eluting beads in the treatment of hepatocellular carcinoma].
Sousa PF; Preto AS; Leão D; Madureira AM; Paquete J; Costa-Maia J; Vilares-Morgado P
Acta Med Port; 2011; 24(1):29-36. PubMed ID: 21672439
[TBL] [Abstract][Full Text] [Related]
3. Transarterial chemoembolization using doxorubicin beads for unresectable hepatocellular carcinoma.
Poston GJ
Onkologie; 2010; 33(1-2):5-6. PubMed ID: 20164653
[No Abstract] [Full Text] [Related]
4. Comparison of Triple-Drug Transcatheter Arterial Chemoembolization (TACE) With Single-Drug TACE Using Doxorubicin-Eluting Beads: Long-Term Survival in 313 Patients.
Gomes AS; Monteleone PA; Sayre JW; Finn RS; Sadeghi S; Tong MJ; Britten CD; Busuttil RW
AJR Am J Roentgenol; 2017 Oct; 209(4):722-732. PubMed ID: 28705059
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up.
Dekervel J; van Malenstein H; Vandecaveye V; Nevens F; van Pelt J; Heye S; Laleman W; Van Steenbergen W; Vaninbroukx J; Verslype C; Maleux G
J Vasc Interv Radiol; 2014 Feb; 25(2):248-55.e1. PubMed ID: 24295569
[TBL] [Abstract][Full Text] [Related]
6. Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC).
Dhanasekaran R; Kooby DA; Staley CA; Kauh JS; Khanna V; Kim HS
J Surg Oncol; 2010 May; 101(6):476-80. PubMed ID: 20213741
[TBL] [Abstract][Full Text] [Related]
7. Meta-Analysis of Doxorubicin-Eluting Beads via Transcatheter Arterial Chemoembolization in the Treatment of Unresectable Hepatocellular Carcinoma.
Hui Y; Ruihua T; Jing L; Yaxiong L; Ji L; Linjie Y; Dongyan S; Mingliang J; Qingsheng H; Junling S
Hepatogastroenterology; 2015 Jun; 62(140):1002-6. PubMed ID: 26902045
[TBL] [Abstract][Full Text] [Related]
8. Safety and feasibility of same-day discharge of patients with unresectable hepatocellular carcinoma treated with doxorubicin drug-eluting bead transcatheter chemoembolization.
Prajapati HJ; Rafi S; El-Rayes BF; Kauh JS; Kooby DA; Kim HS
J Vasc Interv Radiol; 2012 Oct; 23(10):1286-93.e1. PubMed ID: 22999748
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter arterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres for 135 hepatocellular carcinoma patients: single-center experience.
Seki A; Hori S; Kobayashi K; Narumiya S
Cardiovasc Intervent Radiol; 2011 Jun; 34(3):557-65. PubMed ID: 20821211
[TBL] [Abstract][Full Text] [Related]
10. Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma.
Facciorusso A; Mariani L; Sposito C; Spreafico C; Bongini M; Morosi C; Cascella T; Marchianò A; Camerini T; Bhoori S; Brunero F; Barone M; Mazzaferro V
J Gastroenterol Hepatol; 2016 Mar; 31(3):645-53. PubMed ID: 26331807
[TBL] [Abstract][Full Text] [Related]
11. Composition-property relationships for radiopaque composite materials: pre-loaded drug-eluting beads for transarterial chemoembolization.
Kilcup N; Tonkopi E; Abraham RJ; Boyd D; Kehoe S
J Biomater Appl; 2015 Jul; 30(1):93-103. PubMed ID: 25690386
[TBL] [Abstract][Full Text] [Related]
12. [Radiological treatment of hepatocellular carcinoma in 2010].
Rode A
Cancer Radiother; 2011 Feb; 15(1):21-7. PubMed ID: 21257330
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of drug-eluting bead chemoembolization for hepatocellular carcinoma: comparison of small-versus medium-size particles.
Padia SA; Shivaram G; Bastawrous S; Bhargava P; Vo NJ; Vaidya S; Valji K; Harris WP; Hippe DS; Kogut MJ
J Vasc Interv Radiol; 2013 Mar; 24(3):301-6. PubMed ID: 23380737
[TBL] [Abstract][Full Text] [Related]
14. Degradable starch microspheres versus ethiodol and doxorubicin in transarterial chemoembolization of hepatocellular carcinoma.
Niessen C; Unterpaintner E; Goessmann H; Schlitt HJ; Mueller-Schilling M; Wohlgemuth WA; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2014 Feb; 25(2):240-7. PubMed ID: 24291001
[TBL] [Abstract][Full Text] [Related]
15. Switching the loaded agent from epirubicin to cisplatin: salvage transcatheter arterial chemoembolization with drug-eluting microspheres for unresectable hepatocellular carcinoma.
Seki A; Hori S
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):555-62. PubMed ID: 21562932
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead.
Malagari K; Alexopoulou E; Chatzimichail K; Hall B; Koskinas J; Ryan S; Gallardo E; Kelekis A; Gouliamos A; Kelekis D
Abdom Imaging; 2008; 33(5):512-9. PubMed ID: 17938995
[TBL] [Abstract][Full Text] [Related]
17. The effect of doxorubicin loading on response and toxicity with drug-eluting embolization in resectable hepatoma: a dose escalation study.
Klass D; Owen D; Buczkowski A; Chung SW; Scudamore CH; Weiss AA; Yoshida EM; Ford JA; Ho S; Liu DM
Anticancer Res; 2014 Jul; 34(7):3597-606. PubMed ID: 24982375
[TBL] [Abstract][Full Text] [Related]
18. Embolization of hepatocellular carcinoma with drug-eluting beads: doxorubicin tissue concentration and distribution in patient liver explants.
Namur J; Citron SJ; Sellers MT; Dupuis MH; Wassef M; Manfait M; Laurent A
J Hepatol; 2011 Dec; 55(6):1332-8. PubMed ID: 21703190
[TBL] [Abstract][Full Text] [Related]
19. Chemoembolization Adopting Polyethylene Glycol Drug-Eluting Embolics Loaded With Doxorubicin for the Treatment of Hepatocellular Carcinoma.
Aliberti C; Carandina R; Sarti D; Mulazzani L; Pizzirani E; Guadagni S; Fiorentini G
AJR Am J Roentgenol; 2017 Aug; 209(2):430-434. PubMed ID: 28537756
[TBL] [Abstract][Full Text] [Related]
20. Drug-loaded microspheres for the treatment of liver cancer: review of current results.
Kettenbach J; Stadler A; Katzler IV; Schernthaner R; Blum M; Lammer J; Rand T
Cardiovasc Intervent Radiol; 2008; 31(3):468-76. PubMed ID: 18228095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
